Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Nov 26, 2024

SELL
$0.42 - $1.48 $112,644 - $396,936
-268,200 Closed
0 $0
Q4 2020

Nov 22, 2024

SELL
$10.34 - $13.77 $319,506 - $425,493
-30,900 Closed
0 $0
Q3 2020

Nov 22, 2024

BUY
$11.73 - $16.25 $362,457 - $502,125
30,900 New
30,900 $372 Million
Q1 2020

Nov 22, 2024

SELL
$14.83 - $26.72 $2.97 Million - $5.34 Million
-200,000 Reduced 72.67%
75,200 $1.24 Billion
Q4 2019

Nov 22, 2024

BUY
$9.77 - $24.6 $2.69 Million - $6.77 Million
275,200 New
275,200 $6.23 Billion
Q2 2019

Nov 22, 2024

SELL
$11.43 - $15.12 $377,190 - $498,960
-33,000 Reduced 10.71%
275,200 $3.43 Billion
Q1 2019

Nov 22, 2024

BUY
$5.98 - $13.98 $1.84 Million - $4.31 Million
308,200 New
308,200 $3.79 Billion
Q4 2018

Nov 26, 2024

BUY
$5.22 - $10.44 $1.4 Million - $2.8 Million
268,200 New
268,200 $1.58 Billion

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Erste Asset Management Gmb H Portfolio

Follow Erste Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.